A new publication involving insulin detemir was indexed on August 1, 2026. Titled "Efficacy and Safety of Once-Weekly and Once-Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis of Clinical Trials," the paper appears in Diabetes, Obesity & Metabolism. The publication is described as a systematic review and network meta-analysis of clinical trials involving basal insulins, including once-weekly and once-daily formulations. Insulin detemir, an approved basal insulin, is referenced within this body of literature. No specific findings, outcomes, or comparative results from the analysis have been provided at this time. The listing confirms only the existence, title, and journal placement of this publication as of its indexing date. Readers interested in the full scope of the review, including methodology and any reported outcomes, are encouraged to consult the original source directly. This brief does not characterize efficacy, safety signals, or conclusions attributed to insulin detemir or any other basal insulin discussed in the paper. For general background on insulin detemir, including its approved regulatory status, see the compound overview.
New Publication Reviews Once-Weekly vs Daily Basal Insulins Including Detemir
See the full insulin detemir overview
Source: https://pubmed.ncbi.nlm.nih.gov/42225295/